CDSCO Examines Risks of Brand Name Extensions Across Different Drug Formulations
CDSCO has invited stakeholder feedback on drug brand name extensions amid concerns over therapeutic confusion and patient safety, with comments due by 17 July 2026.
CDSCO
Legislation Roundup May 2026: From MGNREGA’s Repeal to Labour Law Updates — 50+ Legislative Developments That Changed Indian Law This May
Discover the latest legislative updates from May 2026, including all updates on new Central and State Legislations, Rules, Notifications; and more.
Cosmetics Are Not Medicines: CDSCO Prohibits Injectable Use
CDSCO issued a notice clarifying cosmetic use, reaffirming that cosmetics are not medicines, are limited to external use, and cannot be injected.
Why you shouldn’t Buy, Use, or Distribute Coldrif Cough Syrup — Read the Advisory
Ministry of Health, ESIC and WHO have issued an advisory banning the purchase, use, and distribution of Coldrif Cough Syrup after child fatalities.
[NOXGUARD v. NONS] Bombay HC denies interim relief to Canadian pharmaceutical company in a confidentiality agreement breach suit
Bombay High Court: While addressing a case relating to confidentiality agreement breach, the Division Bench of Arif S. Doctor and K. R.
Universal Healthcare for All
by Murali Neelakantan† and Ashish Kulkarni††
Cite as: 2022 SCC OnLine Blog Exp 31